Thoroughbred Financial Services’s Tarsus Pharmaceuticals TARS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5,510	Closed	-$283K	–	695
2025 Q1	$283K	Buy	5,510 +765	+16%	+$39.3K	0.02%	560
2024 Q4	$262K	Buy	+4,745	New	+$262K	0.02%	579
2024 Q2	–	Sell	-20,964	Closed	-$762K	–	648
2024 Q1	$762K	Buy	+20,964	New	+$762K	0.07%	238